SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive analyst upgrade that highlights the company's progress in regulatory pathways and validates the therapeutic potential of its lead candidate, Sonelokimab. Investors are actively discussing the stock's significant long-term growth prospects, the potential for a strategic buyout, and the upcoming clinical data readouts that are expected to solidify the drug's position as a best-in-class treatment.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following a series of significant Department of Defense and defense-contractor awards, which have sparked intense community debate over the company's long-term production scalability and balance sheet health. While bulls point to these mission-critical manufacturing contracts as validation of the company's technology, short-sellers and skeptical investors remain focused on ongoing cash burn concerns and the potential for future equity dilution.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is facing intense volatility as shareholders grapple with the end of a major lock-up period and skepticism following a disappointing earnings report that revealed a lack of near-term tenant revenue. The community is sharply divided, with some investors aggressively calling for leadership changes and reporting the firm to the SEC, while others view the current price drop as a strategic buying opportunity in anticipation of future data center power demand.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors gear up for the upcoming fiscal year-end and 10-K filing, with the community highly focused on QNX revenue growth, backlog expansion, and the impact of the new Alloy Kore platform. Shareholders are actively debating management's guidance and the potential for a long-awaited breakout as they look for concrete signs of sustainable double-digit growth.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors weigh strong AI licensing potential and institutional backing against lingering concerns over platform monetization and data integrity. While community members debate whether the stock is a long-term growth play or currently oversold, high-profile litigation updates regarding content scraping continue to fuel active discussion about the company's valuation.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is trending following positive trial data from its TETON-1 study, which demonstrated that nebulized Tyvaso significantly preserves lung function in patients with idiopathic pulmonary fibrosis. The community is actively discussing the potential for a major label expansion that could triple the addressable market for the therapy, leading to multiple analyst price target increases as the company prepares for an FDA submission.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community leans into its roots as a foundational internet meme, bolstered by the restoration of its original RageBuilder and Ragemaker tools. Enthusiasts are actively rallying around the project as a long-term culture play, emphasizing organic growth and community-driven content production as they target long-term valuation milestones.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened trading activity as the company's recent operational updates and offtake agreements drive significant investor interest, leading to strong buying momentum in the stock. The community is actively debating the stock's potential for a breakout, with many discussing the impact of lithium supply-demand dynamics and monitoring insider buying as a key indicator of confidence in future growth.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as the community debates its future following a major strategic shift to discontinue its Aortic Valve Systems, which has sparked discussions about potential impact on long-term margins and resource allocation. Meanwhile, investors are closely monitoring the stock's resilient momentum and recent bullish analyst outlooks that emphasize strong growth in the company's cardiovascular and electrophysiology segments.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is facing significant downward pressure following the release of phase 3 clinical trial data for its thyroid eye disease drug, elegrobart, which failed to demonstrate the level of efficacy compared to IV-based treatments that investors had hoped for. While management emphasizes the drug's safety profile and ongoing clinical progress, market participants are actively debating the competitive threat from established standards of care and potential future rivals, leading to increased volatility and a sharp decline in share price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Firefly Stock Jumps On Department Of Defense Partnership

Firefly Neuroscience, Inc. shares are trading higher Thursday after it announced a public-private partnership with the Department of Defense.read more...

<ul class="summary-bullets"><li>The collaboration is based on earlier studies conducted with the U.S. Naval Medical Center program.</li><li>The total economic impact of PTSD in the U.S. is estimated at $232.2 billion.</li><li>Firefly’s system provides objective neurological data to guide accurate diagnoses and customised treatment plans.</li></ul>Firefly Neuroscience Inc. (AIFF) announced on Thursday an agreement with the Department of War to deploy its artificial intelligence-driven EEG/ERP platform for evaluating and treating active-duty personnel and veterans affected by PTSD and traumatic brain injuries.The initiative focuses on using advanced brain-monitoring technology to address persistent challenges tied to military health.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/AIFF">Firefly Neuroscience stock</a> traded over 33% on Thursday morning.&nbsp;On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bearish’ territory the previous day amid ‘normal’ message volume levels.&nbsp;<h2 class="st-heading-2">Partnership With Defense Sector</h2>The effort builds on earlier research conducted with a U.S. Naval Medical Center program, laying the groundwork for broader adoption across military healthcare systems.Post-traumatic stress disorder and traumatic brain injuries remain among the most pressing issues facing the armed forces. The overall additional economic impact of PTSD in the U.S. is estimated at $232.2 billion, with roughly $42.7 billion linked specifically to service members and veterans.<h2 class="st-heading-2">Technology And Clinical Application</h2>Firefly’s platform, which has received clearance from the U.S. Food and Drug Administration (FDA), uses AI to analyze brainwave activity and deliver objective neurological insights. The system aims to assist clinicians in making more accurate diagnoses, tailoring treatment strategies, and tracking patient progress over time.&nbsp;<blockquote>“We believe that this ongoing strategic partnership positions us well to benefit from the significant and growing U.S. government investment in military brain health — with a validated, FDA-cleared platform.”-Greg Lipschitz, CEO, Firefly</blockquote>AIFF stock has gained over 90% year to date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/navn-stock-draws-cheer-after-strong-q4-bmo-sees-upside-to-share-price-dismisses-ai-concerns/cZ3rw6FRIjz">NAVN Stock Draws Cheer After Strong Q4 – BMO Sees 76% Upside To Share Price, Dismisses AI Concerns</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)

Why Did AIFF Stock Surge Over 33% Today?

The company will deploy its AI-powered EEG/ERP system to assess and treat brain injuries in service members and veterans.

Equity

The company will deploy its AI-powered EEG/ERP system to assess and treat brain injuries in service members and veterans.


Best Artificial Intelligence Stocks To Follow Now - March 15th

SentinelOne, Tempus AI, Firefly Neuroscience, SoundHound AI, and Upstart are the five Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial...

Artificial Intelligence Stocks Worth Watching - March 14th

SentinelOne, Tempus AI, and Firefly Neuroscience are the three Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial intelligence stocks are shares...

Why Firefly Neuroscience Stock Is Soaring Today

Firefly Neuroscience shares are trading higher Friday after it advanced research using its Evoke System to help distinguish ADHD subtypes.read more...

Top Artificial Intelligence Stocks To Watch Now - March 13th

Tempus AI, Firefly Neuroscience, SentinelOne, BigBear.ai, and Hut 8 are the five Artificial Intelligence stocks to watch today, according to MarketBeat's stock screener tool. Artificial intelligence...

AIFF Stock Surged Nearly 50% Today – Here’s Everything To Know About Its AI-Powered Solution To Identify ADHD Subtypes

The company said its technology analyzes EEG brain scans to identify patterns that could distinguish different ADHD subtypes.

Firefly Neuroscience Stock Surges 43% Over Advancement In Differential Diagnosis Of ADHD

(RTTNews) - Shares of Firefly Neuroscience, Inc. (AIFF) are surging roughly 43 percent on Friday morning trading following the announcement of discovery of new brain wave biomarkers for differential...

AI, Diagnostics and Next-Gen Materials Drive Innovation Push Across Emerging Growth Stocks

A wave of developments across emerging technology and life sciences companies underscores how artificial intelligence, advanced diagnostics, and next-generation biomaterials are converging to reshape several high-growth sectors. $ISPC, $AIFF, $KBLB, $BIAF, $ACXP, $KIDZ

What's Going On With Firefly Neuroscience Stock On Friday?

Firefly Neuroscience stock climbs after a major expansion in brain scan partnerships and rapid growth in its EEG data network.read more...

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

Firefly Neuroscience Inc.

Fred Wilson - Union Square Ventures

Abigail Johnson - Fidelity

Jim Cramer - Media Personality

Josh Brown - Ritholtz Wealth Management

A lifetime achievement for industry titans. This honor is reserved for an individual whose groundbreaking contributions have shaped the investing landscape and how we engage with the markets.

Current Price	$2.28
Prev Close	$2.18
Open	$2.21
Dividend Yield	0.00%
50-Day Moving Average	$1.24
Beta	1.29
Avg. Volume	69,935.40
PE Ratio	-0.86

52-Week High	$4.51
52-Week Low	$0.6175
Market Capitalization	$30.99M
EPS (Annual)	-$1.60
Price to Book	3.04
Revenue Per Employee	$7,714.29

AIFF
Firefly Neuroscience Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AIFF News

AIFFFirefly Neuroscience Inc.